MCM
GSK icon

McKinley Capital Management’s GSK GSK Stock Holding History

McKinley Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-7,745
Closed -$421K – 170
2022
Q2 		$421K Buy
+7,745
New +$428K 0.06% 164
2021
Q2 		– Sell
-13,622
Closed -$608K – 183
2021
Q1 		$608K Buy
13,622
+56
+0.4% +$2.54K 0.05% 168
2020
Q4 		$624K Sell
13,566
-335
-2% -$15.4K 0.04% 168
2020
Q3 		$654K Sell
13,901
-1,016
-7% -$50.9K 0.05% 160
2020
Q2 		$760K Sell
14,917
-124
-0.8% -$6.36K 0.05% 153
2020
Q1 		$712K Sell
15,041
-87
-0.6% -$4.64K 0.06% 148
2019
Q4 		$889K Buy
+15,128
New +$841K 0.06% 151
2018
Q2 		– Sell
-9,629
Closed -$470K – 318
2018
Q1 		$470K Sell
9,629
-1,383
-13% -$64.4K 0.03% 168
2017
Q4 		$488K Sell
11,012
-11,142
-50% -$515K 0.02% 255
2017
Q3 		$1.12M Sell
22,154
-636
-3% -$32.3K 0.05% 227
2017
Q2 		$1.23M Sell
22,790
-105
-0.5% -$5.6K 0.05% 218
2017
Q1 		$1.21M Sell
22,895
-536
-2% -$27.2K 0.04% 231
2016
Q4 		$1.13M Sell
23,431
-599
-2% -$29.6K 0.04% 232
2016
Q3 		$1.3M Buy
24,030
+15,875
+195% +$870K 0.05% 233
2016
Q2 		$442K Sell
8,155
-431
-5% -$22.7K 0.02% 267
2016
Q1 		$435K Buy
8,586
+2,751
+47% +$137K 0.02% 252
2015
Q4 		$294K Buy
5,835
+33
+0.6% +$1.68K 0.01% 286
2015
Q3 		$279K Sell
5,802
-488
-8% -$25.4K 0.01% 288
2015
Q2 		$327K Sell
6,290
-423
-6% -$23.8K 0.01% 295
2015
Q1 		$387K Sell
6,713
-31
-0.5% -$1.78K 0.02% 271
2014
Q4 		$360K Sell
6,744
-124
-2% -$6.94K 0.01% 277
2014
Q3 		$395K Sell
6,868
-46
-0.7% -$2.82K 0.02% 264
2014
Q2 		$462K Sell
6,914
-2,220
-24% -$150K 0.02% 239
2014
Q1 		$610K Sell
9,134
-3,807
-29% -$257K 0.03% 260
2013
Q4 		$864K Buy
12,941
+3,394
+36% +$220K 0.03% 257
2013
Q3 		$599K Sell
9,547
-73
-0.8% -$4.7K 0.03% 263
2013
Q2 		$601K Buy
+9,620
New +$611K 0.03% 236

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

McKinley Capital Management's GSK Position: Q3 2022 in Review

McKinley Capital Management sold out of GSK (GSK) in Q3 2022, closing a stake of 7,745 shares — an estimated $421K sold.

McKinley Capital Management first reported a position in GSK in Q2 2013 and held it in 27 quarters. The position peaked at $1.3M in Q3 2016. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • McKinley Capital Management reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
  • McKinley Capital Management sold 7,745 GSK shares in Q3 2022, an estimated $421K.
  • McKinley Capital Management first reported a position in GSK in Q2 2013 and held it in 27 quarters.
  • McKinley Capital Management's GSK position peaked at $1.3M in Q3 2016.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on McKinley Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.